{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:34:48Z","timestamp":1775511288037,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.maturitas.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T18:32:45Z","timestamp":1680201165000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale"],"prefix":"10.1016","volume":"172","author":[{"given":"Santiago","family":"Palacios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"S\u00e1nchez-Borrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Su\u00e1rez \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Lugo Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Javier","family":"Gonz\u00e1lez Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Quijano Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Cancelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Fasero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.maturitas.2023.03.007_bb0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"79","author":"Portman","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2023.03.007_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/PPA.S203614","article-title":"Ospemifene in the management of vulvar and vaginal atrophy: focus on the assessment of patient acceptability and ease of use","volume":"14","author":"Cagnacci","year":"2020","journal-title":"Patient Prefer.Adherence"},{"issue":"13","key":"10.1016\/j.maturitas.2023.03.007_bb0015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2217\/cer-2019-0091","article-title":"Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia","volume":"8","author":"Faught","year":"2019","journal-title":"J. Comp. Eff. Res."},{"issue":"3","key":"10.1016\/j.maturitas.2023.03.007_bb0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/GRF.0000000000000126","article-title":"Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations","volume":"58","author":"Lev-Sagie","year":"2015","journal-title":"Clin. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.maturitas.2023.03.007_bb0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsxm.2017.01.010","article-title":"The Women's EMPOWER Survey: identifying women's perceptions on vulvar and vaginal atrophy and its treatment","volume":"14","author":"Kingsberg","year":"2017","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2023.03.007_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2019.03.013","article-title":"Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women","volume":"124","author":"Panay","year":"2019","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.maturitas.2023.03.007_bb0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/13697137.2018.1446930","article-title":"The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause","volume":"21","author":"Palacios","year":"2018","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.maturitas.2023.03.007_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.maturitas.2023.03.007_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/13697137.2015.1107039","article-title":"Vulvar and vaginal atrophy in four European countries: evidence from the european REVIVE survey","volume":"19","author":"Nappi","year":"2016","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.maturitas.2023.03.007_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13697137.2016.1262840","article-title":"Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions","volume":"20","author":"Palacios","year":"2017","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.maturitas.2023.03.007_bb0055","article-title":"Earlier treatment of vulvovaginal atrophy in post-menopausal women may improve treatment outcomes","volume":"16","author":"Palacios","year":"2019","journal-title":"J. Gynecol. Women's Health"},{"key":"10.1016\/j.maturitas.2023.03.007_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.maturitas.2015.09.001","article-title":"Vaginal atrophy of women in postmenopause: results from a multicentric observational study: the AGATA study","volume":"83","author":"Palma","year":"2016","journal-title":"Maturitas"},{"issue":"8","key":"10.1016\/j.maturitas.2023.03.007_bb0065","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"J. Sex. Med."},{"issue":"6","key":"10.1016\/j.maturitas.2023.03.007_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"issue":"7","key":"10.1016\/j.maturitas.2023.03.007_bb0075","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2023.03.007_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2020.06.019","article-title":"Women with low quality of life by Cervantes-short form scale choose menopausal hormone therapy","volume":"252","author":"Fasero","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.maturitas.2023.03.007_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.maturitas.2012.12.004","article-title":"Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy","volume":"74","author":"Mattsson","year":"2013","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.maturitas.2023.03.007_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/17446651.2019.1657008","article-title":"Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause","volume":"14","author":"Archer","year":"2019","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.maturitas.2023.03.007_bb0095","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.jsxm.2018.10.009","article-title":"Structure of epithelial and stromal compartments of vulvar and vaginal tissue from women with vulvo-vaginal atrophy taking ospemifene","volume":"15","author":"Alvisi","year":"2018","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2023.03.007_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.esxm.2018.03.002","article-title":"Improvements to the vulva, vestibule, urethral meatus, and vagina in women treated with ospemifene for moderate to severe dyspareunia: a prospective vulvoscopic pilot study","volume":"6","author":"Goldstein","year":"2018","journal-title":"Sex Med."},{"issue":"1","key":"10.1016\/j.maturitas.2023.03.007_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/jwh.2017.6385","article-title":"Overall safety of ospemifene in postmenopausal women from placebo-controlled phase II and III trials","volume":"27","author":"Simon","year":"2018","journal-title":"J. Women's Health (Larchmt)"},{"issue":"6","key":"10.1016\/j.maturitas.2023.03.007_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0025-7753(04)74198-6","volume":"122","author":"Palacios","year":"2004","journal-title":"Med. Clin."},{"issue":"4","key":"10.1016\/j.maturitas.2023.03.007_bb0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pog.2014.12.004","article-title":"Grupo de estudio Cervantes, Evaluaci\u00f3n de la calidad de vida en la mujer menop\u00e1usica mediante la escala Cervantes: impacto del tratamiento en la pr\u00e1ctica cl\u00ednica","volume":"58","author":"S\u00e1nchez Borrego","year":"2015","journal-title":"Prog.Obstet.Ginecol."},{"issue":"9","key":"10.1016\/j.maturitas.2023.03.007_bb0120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/jwh.2014.5177","article-title":"The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe","volume":"24","author":"DiBonaventura","year":"2015","journal-title":"J. Women's Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.maturitas.2023.03.007_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/GME.0000000000000321","article-title":"Structural validity of a 16-item abridged version of the Cervantes Health-related Quality of Life scale for menopause: the Cervantes Short-form Scale","volume":"22","author":"Coronado","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2023.03.007_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2015.10.013","article-title":"Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women","volume":"84","author":"Coronado","year":"2016","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2023.03.007_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00404-019-05238-1","article-title":"The impact of perimenopausal symptomatology, sociodemographic status and knowledge of menopause on women's quality of life","volume":"301","author":"Larroy","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.maturitas.2023.03.007_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13697137.2017.1421921","article-title":"Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study","volume":"21","author":"Moral","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2023.03.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/13697137.2023.2190508","article-title":"Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA study","author":"S\u00e1nchez-Borrego","year":"2023","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2023.03.007_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/13697137.2014.954996","article-title":"Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial","volume":"18","author":"Constantine","year":"2015","journal-title":"Climacteric"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222300052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222300052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:21:30Z","timestamp":1759915290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851222300052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"alternative-id":["S037851222300052X"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2023.03.007","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}